logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Andrew Satlin

transposon therapeutics, inc.

49H指数
135论文数
9.4K被引数
收录论文 41
发表时间
logo
Phase 2a Randomized Controlled Trial of TPN-101, A Nucleoside Reverse Transcriptase Inhibitor, in Progressive Supranuclear Palsy2a期随机对照试验：TPN-101（一种核苷类逆转录酶抑制剂）在进行性核上性麻痹中的应用
errMovement Disorders
IF7.6
err2026-08-24
err0
PREAI
errAndrew Satlin MD; Michael G. Cordingley PhD; Debra K. Liebert MS, MBA; Walter Bee PhD; Ethan G. Geier PhD; John M. Sedivy PhD; Jay Soto; Jianmin Duan PhD; Samuel P. Dickson PhD; Leslie Chu PhD; Eckard Weber MD
err分享
err收藏
Design considerations for C9orf72 disease prevention trialsC9orf72疾病预防试验的设计考虑
errBRAIN
IF11.7
err2025-10-01
err0
errOAAI
errBenatar, Michael; Staffaroni, Adam M.; Wuu, Joanne; McDermott, Michael P.; Quintana, Melanie; Swidler, Jean; Andersen, Gail; Huey, Edward D.; Turner, Martin R.; Macklin, Eric A.; Berry, James D.; McMillan, Corey T.; Gendron, Tania; Onyike, Chiadi; Rosen, Howard; Heuer, Hilary W.; Grignon, Anne-Laure; Dave, Kuldip D.; Balas, Calaneet; Gleixner, Amanda; Satlin, Andrew; Dunn, Billy; Dacks, Penny; Boxer, Adam L.
err分享
err收藏
Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial
errBIPOLAR DISORDERS
IF4.5
err2023-02-26
err9
errOAAI
errSuppes, Trisha; Durgam, Suresh; Kozauer, Susan G.; Chen, Richard; Lakkis, Hassan D.; Davis, Robert E.; Satlin, Andrew; Vanover, Kimberly E.; Mates, Sharon; McIntyre, Roger S.; Tohen, Mauricio
err分享
err收藏
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial
errAMERICAN JOURNAL OF PSYCHIATRY
IF14.7
err2021-12-01
err58
PREAI
errCalabrese, Joseph R.; Durgam, Suresh; Satlin, Andrew; Vanover, Kimberly E.; Davis, Robert E.; Chen, Richard; Kozauer, Susan G.; Mates, Sharon; Sachs, Gary S.
err分享
err收藏
Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure
errjacc heart failure
IF8.4
err2021-09-01
err18
errOAAI
errGilotra, Nisha A.; DeVore, Adam D.; Povsic, Thomas J.; Hays, Allison G.; Hahn, Virginia S.; Agunbiade, Tolu A.; DeLong, Allison; Satlin, Andrew; Chen, Richard; Davis, Robert; Kass, David A.
err分享
err收藏
Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia
errSCHIZOPHRENIA RESEARCH
IF3.5
err2021-02-01
err19
errOAAI
errCorrell, Christoph U.; Vanover, Kimberly E.; Davis, Robert E.; Chen, Richard; Satlin, Andrew; Mates, Sharon
err分享
err收藏
Cardiometabolic safety of lumateperone (ITI-007): post hoc analyses of short-term randomized trials and an open-label long-term study
errEUROPEAN NEUROPSYCHOPHARMACOLOGY
IF6.7
err2020-11-01
err0
PREAI
errSatlin, A.; Durgam, S.; Vanover, K. E.; Davis, R. E.; Chen, R.; Mates, S.; Correll, C. U.
err分享
err收藏
Efficacy and safety of lumateperone (ITI-007) in the treatment of depressive episodes associated with bipolar I and II disorders
errEUROPEAN NEUROPSYCHOPHARMACOLOGY
IF6.7
err2020-11-01
err0
PREAI
errDurgam, S.; Satlin, A.; Vanover, K. E.; Davis, R. E.; Edwards, J. B.; Kozauer, S. G.; Huo, J.; Mates, S.; Calabrese, J. R.
err分享
err收藏
Results from a 12-month open-label safety study of lumateperone (ITI-007) in patients with stable symptoms of schizophrenia
errEUROPEAN NEUROPSYCHOPHARMACOLOGY
IF6.7
err2019-12-01
err1
PREAI
errCorrell, C. U.; Vanover, K. E.; Durgam, S.; Weingart, M.; Davis, R.; Satlin, A.
err分享
err收藏
Efficacy and safety of lumateperone tosylate 42mg in the treatment of schizophrenia: A pooled analysis of phase 2 and 3 studies
errEUROPEAN NEUROPSYCHOPHARMACOLOGY
IF6.7
err2019-12-01
err4
PREAI
errKane, J. M.; Vanover, K. E.; Durgam, S.; Weingart, M.; Davis, R.; Satlin, A.; Tamminga, C.
err分享
err收藏
FAVORABLE LONG-TERM SAFETY PROFILE OF LUMATEPERONE IITI-007): RESULTS FROM A 12 MONTH OPEN LABEL SAFETY STUDY FOR LUMATEPERONE IN PATIENTS WITH STABLE SYMPTOMS OF SCHIZOPHRENIA
errSCHIZOPHRENIA BULLETIN
IF4.8
err2019-04-09
err8
errOAAI
errVanover, Kimberly; Satlin, Andrew; Durgam, Saresh; Weingart, Michal; Saillard, Jelena; Sanchez, Juan; Hossain, Shawon; Glass, Steven; Kozauer, Susan; Mates, Sharon; Davis, Robert
err分享
err收藏
Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial
errAMERICAN HEART JOURNAL
IF3.5
err2018-08-01
err12
PREAI
errBohula, Erin A.; Scirica, Benjamin M.; Fanola, Christina; Inzucchi, Silvio E.; Keech, Anthony; McGuire, Darren K.; Smith, Steven R.; Abrahamsen, Tim; Francis, Bruce H.; Miao, Wenfeng; Perdomo, Carlos A.; Satlin, Andrew; Wiviott, Stephen D.; Sabatine, Marc S.
err分享
err收藏
Unique Pharmacology and Clinical Evidence Supporting the Antidepressant Therapeutic Potential of Lumateperone
errBIOLOGICAL PSYCHIATRY
IF9
err2018-05-01
err1
PREAI
errSnyder, Gretchen; Davis, Robert; Dutheil, Sophie; Hendrick, Joseph; Zhang, Lei; Wennogle, Lawrence; Satlin, Andrew; Marcus, Monica; Mates, Sharon; Vanover, Kim; Svensson, Torgny
err分享
err收藏
LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA: PLACEBO-CONTROLLED CLINICAL TRIALS AND AN OPEN-LABEL SAFETY SWITCHING STUDY
errSCHIZOPHRENIA BULLETIN
IF4.8
err2018-04-01
err19
errOAAI
errVanover, Kimberly; Dmitrienko, Alex; Glass, Steven; Kozauer, Susan; Saillard, Jelena; Weingart, Michal; Satlin, Andrew; Mates, Sharon; Correll, Christoph; Davis, Robert
err分享
err收藏
LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA
errSCHIZOPHRENIA BULLETIN
IF4.8
err2018-04-01
err8
errOAAI
errDavis, Robert; Dmitrienko, Alex; Glass, Steven; Kozauer, Susan; Saillard, Jelena; Weingart, Michal; Satlin, Andrew; Mates, Sharon; Correll, Christoph; Vanover, Kimberly
err分享
err收藏
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study莱博雷生：一种用于治疗失眠障碍的双重食欲素受体拮抗剂（DORA）——一项基于贝叶斯方法的自适应、随机、双盲、安慰剂对照研究结果
errJOURNAL OF CLINICAL SLEEP MEDICINE
IF2.9
err2017-11-15
err117
errOAAI
errMurphy, Patricia; Moline, Margaret; Mayleben, David; Rosenberg, Russell; Zammit, Gary; Pinner, Kate; Dhadda, Shobha; Hong, Quan; Giorgi, Luigi; Satlin, Andrew
err分享
err收藏
Safety and tolerability of BAN2401-a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody
errALZHEIMERS RESEARCH & THERAPY
IF7.6
err2016-04-06
err270
errOAAI
errLogovinsky, Veronika; Satlin, Andrew; Lai, Robert; Swanson, Chad; Kaplow, June; Osswald, Gunilla; Basun, Hans; Lannfelt, Lars
err分享
err收藏
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
errJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
IF7.5
err2016-03-23
err110
errOAAI
errWang, Jinping; Logovinsky, Veronika; Hendrix, Suzanne B.; Stanworth, Stephanie H.; Perdomo, Carlos; Xu, Lu; Dhadda, Shobha; Do, Ira; Rabe, Martin; Luthman, Johan; Cummings, Jeffrey; Satlin, Andrew
err分享
err收藏
Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project
errLANCET PSYCHIATRY
IF24.8
err2016-02-01
err149
PREAI
errRitchie, Craig W.; Molinuevo, Jose Luis; Truyen, Luc; Satlin, Andrew; Van der Geyten, Serge; Lovestone, Simon
err分享
err收藏
DEPRESSION IN A LONG-TERM-CARE FACILITY - CLINICAL-FEATURES AND DISCORDANCE BETWEEN NURSING ASSESSMENT AND PATIENT INTERVIEWS
errJOURNAL OF THE AMERICAN GERIATRICS SOCIETY
IF4.5
err2015-04-27
err60
PREAI
errBURROWS, AB; SATLIN, A; SALZMAN, C; NOBEL, K; LIPSITZ, LA
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jeffrey L. Cummings
H 指数: 176 · 论文数: 1.5K
C
Christoph U. Correll
H 指数: 145 · 论文数: 2.0K
M
Marc S. Sabatine
H 指数: 143 · 论文数: 982
D
David A. Kass
H 指数: 137 · 论文数: 790
R
Roger S. McIntyre
H 指数: 125 · 论文数: 1.4K
查看更多